CDC Small Business Engagement Summit
ID: 77584Type: Special Notice
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFCENTERS FOR DISEASE CONTROL AND PREVENTIONCDC OFFICE OF ACQUISITION SERVICESATLANTA, GA, 30333, USA

Original Source

https://sam.gov/opp/cd0ba32118634556a5ed86f9be180937/view
Timeline
    Description

    Presolicitation HEALTH AND HUMAN SERVICES, DEPARTMENT OF intends to award a sole source contract to QIAGEN, LLC for the procurement of an EZ! Advanced XL System. This system is typically used for In-Vitro Diagnostic Substance Manufacturing. The contract is for supplies or services under the authority of FAR 13.106-1(b) (SAP) and 41 U.S.C. 3304(a)(1). Interested parties may submit proposals within five days of the issuance of this notice. The deadline for submission is 06:00AM, July 24, 2023.

    Point(s) of Contact
    Rotravius Burch
    (770) 488-2457
    vwa8@cdc.gov
    Lauren Peel
    (770) 488-2649
    ijt9@cdc.gov
    Lifecycle
    Title
    Type
    CDC Small Business Engagement Summit
    Currently viewing
    Special Notice
    Notice of Intent to Award to Sole Source - EZ! Advanced XL System
    Presolicitation
    Similar Opportunities
    Title: Global Life Sciences Sepax Cell Separation Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a firm fixed-price contract for the procurement of Global Life Sciences Sepax Cell Separation Kits and Ficoll Paque Premium reagents. The NIH's Department of Transfusion Medicine requires these items to support the manufacturing of cell-based therapies for patients with advanced metastatic cancer, utilizing the Sepax C-Pro Cell Processing Instruments. This acquisition is being conducted under the Simplified Acquisition Procedures, allowing for a sole-source award to Cytiva-Global Life Sciences Solutions USA LLC, with capability statements due by November 3, 2024, at 12:00 PM EST. Interested parties can direct inquiries to Sheri Eiri at sheri.eiri@nih.gov.
    BD Biosciences Proprietary Instrumentation Package and Reagent Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to procure a proprietary instrumentation package and reagent kits from Becton, Dickinson & Company for the Department of Laboratory Medicine. This acquisition aims to secure essential supplies, including instrument rentals and quality control materials, necessary for the operation of the Hematology Flow Cytometry Service, which plays a critical role in patient care and research. The procurement is vital for maintaining the laboratory's capacity to deliver timely and accurate results, as the specified reagent kits are uniquely compatible with the existing BD Rhapsody™ single cell analysis system. Interested parties may submit capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by November 14, 2024, at 6:30 AM EST, as this is a presolicitation notice and not a request for quotations.
    CYTEK AURORA 5 LASER WITH LOADER - UV/V/B/YG/R - PREMIUM SERVICE AGREEMENT
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for a premium service agreement for a Cytek Aurora 5 laser with loader, which is essential for advanced laboratory applications. The procurement includes comprehensive maintenance services, such as preventive inspections, technical support, and on-site assistance, ensuring optimal functionality of the equipment throughout the contract period from December 1, 2024, to November 20, 2025. This acquisition is critical for supporting the NIH's research initiatives in allergy and infectious diseases, emphasizing the importance of reliable laboratory equipment and services. Interested vendors must submit their quotations via the NIAID electronic Simplified Acquisition Submission System (eSASS) by November 13, 2024, at 12:00 am EST, and can contact Maliaka Pinkney or Jesse D Weidow for further inquiries.
    BPA Master - Reagents for Luminex 3D
    Active
    Dept Of Defense
    The Defense Health Agency (DHA) intends to establish a Blanket Purchase Agreement on a sole source basis with One Lambda, Inc. for the procurement of laboratory reagents essential for the Luminex 3D Instrument System. This procurement is justified under the statutory authority permitting Other than Full and Open Competition, as outlined in FAR 6.302-1, indicating that only One Lambda can meet the agency's specific requirements. The reagents are crucial for immunology testing and transplantation compatibility, supporting the operations of the Immunology Lab Department at Walter Reed National Military Medical Center. Interested parties capable of providing the requested reagents must submit their capabilities and pricing by 10:00 am EST on November 8, 2024, via email to the designated contacts, Ealed Nuru and Erica S. Oh.
    Notice of Intent to Sole Source; Siemens Medical Solutions
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract to Siemens Medical Solutions for the maintenance and support of the Syngo Dynamics application. This acquisition aims to activate a software maintenance agreement for the proprietary Syngo Dynamics General Ultrasound software, which is critical for daily operations in patient care at the NIH Clinical Center. The contract will be awarded under the Federal Acquisition Regulation (FAR) Part 13, allowing for a sole source procurement due to the unique nature of the software. Interested parties may express their interest and capabilities to Kristin Nagashima at kristin.nagashima@nih.gov by November 15, 2024, at 10 AM EST.
    Notice of Intent to Sole Source - Biosearch Technologies
    Active
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) intends to negotiate a sole source contract with Biosearch Technologies, Inc. for the production of proprietary PCR kits essential for the Laboratory Response Network (LRN). The procurement aims to ensure a consistent supply of reagents necessary for detecting biothreat agents and emerging infectious diseases, which are critical for national preparedness and response capabilities. These kits, which must comply with FDA quality standards, are vital for high-security laboratories and are designed to identify various bioterrorism agents. Interested parties may submit capability statements or proposals to Matthew Nelson at mnelson2@cdc.gov by November 7, 2024, at 3:30 PM EST for consideration.
    Notice of Intent to Sole Source to HEL Inc.
    Active
    Dept Of Defense
    The Department of Defense, specifically the Naval Research Laboratory (NRL), intends to sole source a BioXplorer 400 system from HEL Inc. for its biomanufacturing research efforts. This specialized gas fermentation platform is required to integrate seamlessly with existing HEL Inc. equipment and must feature four independently controlled reactors capable of managing multiple gas streams, including hydrogen. The procurement process is justified under federal regulations that permit negotiation with a single source due to the unique specifications of the equipment, emphasizing the importance of compatibility and performance in advancing NRL's research capabilities. Interested vendors may submit capability statements to Graham W.J. Fisher at graham.w.fisher.civ@us.navy.mil, although this does not guarantee a competitive procurement process.
    MAINTENANCE AND REPAIR SERVICE AGREEMENT FOR NEXTSEQ 2000 (S/N: VH74007)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to negotiate a maintenance and repair service agreement for the Illumina NextSeq 2000 system, serial number VH74007. The contract will cover a 12-month support plan, including full maintenance for parts, labor, and travel, as well as preventative maintenance inspections, remote technical support, and software updates. This service is crucial for the Laboratory of Parasitic Diseases to ensure the operational efficiency of their sequencing equipment. Interested vendors must submit their capability statements and relevant documentation by 12:00 PM EST on November 15, 2024, via the NIH electronic Simplified Acquisition Submission System (eSASS), with all inquiries directed to Mildred Moss at mildred.moss@nih.gov or Tonia Alexander at talexander@niaid.nih.gov.
    Sources Sought-BioFire Reagents and Test Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is conducting a Sources Sought announcement to identify potential qualified small businesses capable of supplying BioFire Defense reagents and test kits. The NIH's Department of Laboratory Medicine requires these reagents for their BioFire FilmArray analyzers, which are essential for the rapid detection of infectious agents from clinical samples, thereby facilitating timely treatment. Interested vendors must submit their company information, including a capability statement, by 12:00 PM EST on November 7, 2024, to Sheri Eiri at sheri.eiri@nih.gov, as the government will not reimburse any costs associated with this request.
    Service Maintenance Agreement for an Thermo Q Exactive Orbitrap Mass Spectrometer
    Active
    Health And Human Services, Department Of
    The U.S. Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking proposals for a Service Maintenance Agreement for the Thermo Q Exactive Orbitrap Mass Spectrometer System. This procurement aims to ensure the continuous operation and reliability of the mass spectrometer, which is essential for the FDA's Center for Biologics Evaluation and Research in synthesizing high-quality peptides for advanced research and vaccine evaluation. The contract will cover a base year with four additional option years, requiring maintenance and repairs to be conducted by certified Original Equipment Manufacturer (OEM) technicians, with a commitment to corrective services within 2-3 business days. Interested vendors can contact Carole Edwards at Carole.Edwards@fda.hhs.gov or call 870-543-7459 for further details regarding the solicitation, which is outlined in the attached Combined Synopsis/Solicitation Number: 75F40125Q126048.